EICHORCondition: Lymphoma · Sponsor: SWOG Cancer Research Network
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies can locate tumor cells and either kill them or deliver radioactive tumor-killing substances to them without harming normal cells. It is not yet known which monoclonal antibody plus combination chemotherapy regimen is more effective in treating non-Hodgkin's lymphoma. PURPOSE: This randomized phase III trial is comparing 2 different monoclonal antibodies given together with combination chemotherapy to see how well they work in treating patients with newly-diagnosed non-Hodgkin's lymphoma.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Alaska Regional Hospital Cancer Center | Anchorage, Alaska, United States | — |
| Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital | Fairbanks, Alaska, United States | — |
| Hembree Mercy Cancer Center at St. Edward Mercy Medical Center | Fort Smith, Arkansas, United States | — |
| Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Alta Bates Summit Comprehensive Cancer Center | Berkeley, California, United States | — |
| Peninsula Medical Center | Burlingame, California, United States | — |
| Marin Cancer Institute at Marin General Hospital | Greenbrae, California, United States | — |
| Sutter Health - Western Division Cancer Research Group | Greenbrae, California, United States | — |
| Desert Regional Medical Center Comprehensive Cancer Center | Palm Springs, California, United States | — |
| University of California Davis Cancer Center | Sacramento, California, United States | — |
| California Pacific Medical Center - California Campus | San Francisco, California, United States | — |
| Stanford Cancer Center | Stanford, California, United States | — |
+ 247 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00006721